BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang Z, Yu X, Zhou B, Zhang J, Chang J. Circular RNA circ_0026359 Enhances Cisplatin Resistance in Gastric Cancer via Targeting miR-1200/POLD4 Pathway. Biomed Res Int. 2020;2020:5103272. [PMID: 32855967 DOI: 10.1155/2020/5103272] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang J, Zhang Y, Liu L, Yang T, Song J. Circular RNAs: new biomarkers of chemoresistance in cancer. Cancer Biol Med 2021:j. [PMID: 33738995 DOI: 10.20892/j.issn.2095-3941.2020.0312] [Reference Citation Analysis]
2 Wu Z, Liu P, Zhang G. Identification of circRNA-miRNA-Immune-Related mRNA Regulatory Network in Gastric Cancer. Front Oncol 2022;12:816884. [PMID: 35280778 DOI: 10.3389/fonc.2022.816884] [Reference Citation Analysis]
3 Lin JC, Zhu NX, Wu LF. Research progress of circRNAs in chemotherapy resistance of digestive system neoplasms. Shijie Huaren Xiaohua Zazhi 2021; 29(21): 1237-1247 [DOI: 10.11569/wcjd.v29.i21.1237] [Reference Citation Analysis]
4 Liu Y, Ao X, Ji G, Zhang Y, Yu W, Wang J. Mechanisms of Action And Clinical Implications of MicroRNAs in the Drug Resistance of Gastric Cancer. Front Oncol 2021;11:768918. [PMID: 34912714 DOI: 10.3389/fonc.2021.768918] [Reference Citation Analysis]
5 Sun M, Liu X, Zhao W, Zhang B, Deng P. Circ_0058063 contributes to cisplatin-resistance of bladder cancer cells by upregulating B2M through acting as RNA sponges for miR-335-5p. BMC Cancer 2022;22:313. [PMID: 35321689 DOI: 10.1186/s12885-022-09419-1] [Reference Citation Analysis]
6 Zhang R, Zhao H, Yuan H, Wu J, Liu H, Sun S, Zhang Z, Wang J. CircARVCF Contributes to Cisplatin Resistance in Gastric Cancer by Altering miR-1205 and FGFR1. Front Genet 2021;12:767590. [PMID: 34899853 DOI: 10.3389/fgene.2021.767590] [Reference Citation Analysis]
7 Wang S, Qian L, Cao T, Xu L, Jin Y, Hu H, Fu Q, Li Q, Wang Y, Wang J, Xia Y, Huang X. Advances in the Study of CircRNAs in Tumor Drug Resistance. Front Oncol 2022;12:868363. [DOI: 10.3389/fonc.2022.868363] [Reference Citation Analysis]
8 Bai Y, Li Y, Bai J, Zhang Y. Hsa_circ_0004674 promotes osteosarcoma doxorubicin resistance by regulating the miR-342-3p/FBN1 axis. J Orthop Surg Res 2021;16:510. [PMID: 34407841 DOI: 10.1186/s13018-021-02631-y] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Zangouei AS, Moghbeli M. MicroRNAs as the critical regulators of cisplatin resistance in gastric tumor cells. Genes Environ 2021;43:21. [PMID: 34099061 DOI: 10.1186/s41021-021-00192-4] [Reference Citation Analysis]
10 Mu Q, Lv Y, Luo C, Liu X, Huang C, Xiu Y, Tang L. Research Progress on the Functions and Mechanism of circRNA in Cisplatin Resistance in Tumors. Front Pharmacol 2021;12:709324. [PMID: 34566636 DOI: 10.3389/fphar.2021.709324] [Reference Citation Analysis]
11 Deng P, Sun M, Zhao WY, Hou B, Li K, Zhang T, Gu F. Circular RNA circVAPA promotes chemotherapy drug resistance in gastric cancer progression by regulating miR-125b-5p/STAT3 axis. World J Gastroenterol 2021; 27(6): 487-500 [PMID: 33642823 DOI: 10.3748/wjg.v27.i6.487] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 10] [Article Influence: 11.0] [Reference Citation Analysis]
12 Feng D, Lv J, Li K, Cao Q, Han J, Yu H, Cheng Y, Zhuang J, Cai L, Yang H, Yang X, Lu Q. CircZNF609 promotes bladder cancer progression and inhibits cisplatin sensitivity via miR-1200/CDC25B pathway. Cell Biol Toxicol 2022. [PMID: 35567596 DOI: 10.1007/s10565-022-09715-3] [Reference Citation Analysis]
13 Wang M, Yu F, Zhang Y, Zhang L, Chang W, Wang K. The Emerging Roles of Circular RNAs in the Chemoresistance of Gastrointestinal Cancer. Front Cell Dev Biol 2022;10:821609. [DOI: 10.3389/fcell.2022.821609] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]